Xiao-yan Qiu

12 Middle Urumqi Road, 200040
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Skin toxicity associated with immune checkpoint inhibitors based on the FDA adverse event reporting system 2011 - 2023 data.

Skin toxicity associated with immune checkpoint inhibitors based on the FDA adverse event reporting system 2011 - 2023 data.

Journal: International journal of clinical pharmacology and therapeutics

Published: July 22, 2025

Identification of drug combinations to reduce the risk of pioglitazone-related bladder cancer using the FDA adverse event reporting system database.

Identification of drug combinations to reduce the risk of pioglitazone-related bladder cancer using the FDA adverse event reporting system database.

Journal: Expert opinion on drug safety

Published: May 05, 2025

Reassessment of pioglitazone and bladder cancer based on FAERS database.

Reassessment of pioglitazone and bladder cancer based on FAERS database.

Journal: Expert opinion on drug safety

Published: September 20, 2024

Rhabdomyolysis associated with concomitant use of colchicine and statins in the real world: identifying the likelihood of drug-drug interactions through the FDA adverse event reporting system.

Rhabdomyolysis associated with concomitant use of colchicine and statins in the real world: identifying the likelihood of drug-drug interactions through the FDA adverse event reporting system.

Journal: Frontiers in pharmacology

Published: June 07, 2024

Major adverse cardiovascular events associated with testosterone treatment: a pharmacovigilance study of the FAERS database.

Major adverse cardiovascular events associated with testosterone treatment: a pharmacovigilance study of the FAERS database.

Journal: Frontiers in pharmacology

Published: March 08, 2023

Sodium-glucose co-transporter-2 inhibitor (SGLT2i) treatment and risk of osteomyelitis: A pharmacovigilance study of the FAERS database.

Sodium-glucose co-transporter-2 inhibitor (SGLT2i) treatment and risk of osteomyelitis: A pharmacovigilance study of the FAERS database.

Journal: Frontiers in pharmacology

Published: November 29, 2022

Skin cancer signal associated with phosphodiesterase inhibitors: gaining insight through the FDA pharmacovigilance database.

Skin cancer signal associated with phosphodiesterase inhibitors: gaining insight through the FDA pharmacovigilance database.

Journal: Expert opinion on drug safety

Published: November 05, 2022

Population Pharmacokinetic Modeling Combined With Machine Learning Approach Improved Tacrolimus Trough Concentration Prediction in Chinese Adult Liver Transplant Recipients.

Population Pharmacokinetic Modeling Combined With Machine Learning Approach Improved Tacrolimus Trough Concentration Prediction in Chinese Adult Liver Transplant Recipients.

Journal: Journal of clinical pharmacology

Published: June 21, 2022

Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS.

Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS.

Journal: Frontiers in pharmacology

Published: April 16, 2022

Association between cyclin-dependent kinase 4/6 inhibitors and venous thromboembolism: analysis of F.A.E.R.S. data.

Association between cyclin-dependent kinase 4/6 inhibitors and venous thromboembolism: analysis of F.A.E.R.S. data.

Journal: Expert opinion on drug safety

Published: September 28, 2021

Pharmacokinetics Evaluation of Mycophenolic Acid and Its Glucuronide Metabolite in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium and Tacrolimus.

Pharmacokinetics Evaluation of Mycophenolic Acid and Its Glucuronide Metabolite in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium and Tacrolimus.

Journal: Therapeutic drug monitoring

Published: May 31, 2018

External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients.

External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients.

Journal: British journal of clinical pharmacology

Published: March 27, 2017

Showing 1-12 of 16

Last Updated: 09/26/2026